Company description
Metabio, a Greek health-tech company specializing in end-to-end solutions for the integration, management, and utilization of human biospecimens and associated health data across the entire biomedical value chain. e-MetaBio’s ecosystem, connects patients, healthcare providers, biobanks, and researchers, enabling real-time data harmonization, longitudinal tracking, and secure data exchange without disrupting existing infrastructures. The company combines advanced digital platforms with consultancy services for the design and implementation of biobanks, supporting organizations in building compliant, scalable, and research-ready next-generation infrastructures.
Metabio’s technology incorporates dynamic patient-centric e-consent, data analytics, and interoperability services, enhancing research efficiency and enabling personalized medicine approaches. By transforming fragmented clinical and laboratory data into structured, high-value assets, Metabio supports healthcare networks, research institutions, and industry partners in accelerating biomedical research, improving patient outcomes, and creating new opportunities for collaboration, innovation, and sustainable growth across global markets.
Team
Metabio has three departments, the Biomedical, the Technical and the Business. The Î’iomedical is composed of individuals with expertise in Life Sciences and Biobanking such as Molecular Biologists, Geneticists and Biologists. The Technical department is composed of Engineers and Bioinformaticians and the Business team with executives from the Pharma and Biotesch industry in Europe and elsewhere.
Countries of operation
Bulgaria, France, Greece, South Africa, United Arab Emirates, United States, Zambia
Ownership of company
Greece
Year of incorporation
2018
Number of years since incorporated
8
Project pitch
Metabio is showcasing its end-to-end biobanking and health data integration ecosystem, designed to help healthcare providers, research institutions, and governments unlock the value of human biospecimens and associated data. Through our interoperable e-MetaBio® platform, combined with biobank development consultancy, we enable the creation of structured, compliant, and scalable infrastructures for data-driven healthcare and biomedical research.
At the forum, we are seeking strategic partnerships with hospitals, research centers, public health organizations, and investors to deploy biobanking and real-world data ecosystems in emerging markets, starting with Nigeria. We are particularly interested in collaborations that support local biobank development, clinical research enablement, and cross-border data networks connecting Africa with Europe.
We are also open to investment and joint ventures to scale our technology and infrastructure, accelerate market entry, and co-develop regional hubs for biospecimen and data-driven research, contributing to improved healthcare outcomes and innovation capacity.
Type of Project:
Technology and Services in Life Sciences.
Stage of project
Scale up
Total project cost (in EUR)
€650,000
Annual revenue (in EUR)
100.000-250.000 EUR
Number of employees
Between 10 and 50 employees
Financing needs (in EUR)
€1,000,000
Type of financing needed
Joint Venture, Investment
Planned allocation of fundraising capital
Business Development in Africa, establish local branch and expand current team capabilities and strengths.
Website/URL
https://metab.io/